Core Scientific (NASDAQ: CORZ) reported Q2 EPS of $0.18, $0.08 better than the analyst estimate of $0.10. Revenue for the quarter came in at $164 million versus the consensus estimate of $160.69 million.

For earnings history and earnings-related data on Core Scientific (CORZ) click here.